KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Quest Diagnostics (DGX) EBIT (2016 - 2025)

Historic EBIT for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $386.0 million.

  • Quest Diagnostics' EBIT rose 1696.97% to $386.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 2228.43%. This contributed to the annual value of $1.3 billion for FY2024, which is 665.61% up from last year.
  • Per Quest Diagnostics' latest filing, its EBIT stood at $386.0 million for Q3 2025, which was up 1696.97% from $438.0 million recorded in Q2 2025.
  • Quest Diagnostics' EBIT's 5-year high stood at $660.0 million during Q1 2021, with a 5-year trough of $135.0 million in Q4 2022.
  • Over the past 5 years, Quest Diagnostics' median EBIT value was $361.0 million (recorded in 2024), while the average stood at $399.3 million.
  • In the last 5 years, Quest Diagnostics' EBIT skyrocketed by 27714.29% in 2021 and then crashed by 7481.34% in 2022.
  • Quarter analysis of 5 years shows Quest Diagnostics' EBIT stood at $536.0 million in 2021, then tumbled by 74.81% to $135.0 million in 2022, then surged by 97.78% to $267.0 million in 2023, then skyrocketed by 35.21% to $361.0 million in 2024, then grew by 6.93% to $386.0 million in 2025.
  • Its EBIT was $386.0 million in Q3 2025, compared to $438.0 million in Q2 2025 and $346.0 million in Q1 2025.